LABU | Direxion Daily S&P Biotech Bull 3X ETFAMEXETF golden cross and death cross projections, cross tests and history

$241.18
+$12.80 (+5.60%)

Direxion Daily S&P Biotech Bull 3X ETF (LABU) is an AMEX-listed ETF that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA has sat above the 200 on the daily since Sep 2025, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits between the 50 and the 200; on the weekly it is above both.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
between the two $241.18 vs 50 $258.08 / 200 $217.21
Projection
No cross projected
Test
No active test
Last cross
Golden cross 29 Sep 2025 ยท projected 29 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $247.22 vs 50 $205.45 / 200 $129.12
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 20 Apr 2026 ยท projected 18 bars out

4-hour as of 3 Nov 16:00 ET

Price
between the two $241.18 vs 50 $234.01 / 200 $261.37
Projection
No cross projected
Test
No active test
Last cross
Death cross 14 Oct 2026 ยท projected 23 bars out

Cross history

26
crosses on record since 2018
13 golden13 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
14 Oct 2026Death4-hour23 bars outNot tested
week of 20 Apr 2026Golden moderateweekly18 bars outNot tested
17 Apr 2026Golden4-hour29 bars outNot tested
30 Mar 2026Death4-hour28 bars out1 bar cross test
29 Sep 2025Golden moderatedaily29 bars outNot tested

About LABU

ExchangeAMEX
InstrumentETF
Median $ volume, 60 d$90.5M
4-hour coverageYes, since Oct 2025
History on recordSince 2018

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.